Email updates

Keep up to date with the latest news and content from BMC Biotechnology and BioMed Central.

Open Access Methodology article

High yield expression of catalytically active USP18 (UBP43) using a Trigger Factor fusion system

Anja Basters12, Lars Ketscher12, Elke Deuerling3, Christoph Arkona4, Jörg Rademann4, Klaus-Peter Knobeloch1* and Günter Fritz1*

Author Affiliations

1 Department of Neuropathology, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany

2 Faculty of Biology, University of Freiburg, Schänzlestrasse 1, 79104, Freiburg, Germany

3 Department of Biology, University of Konstanz, 78457, Constance, Germany

4 University of Leipzig, Pharmazeutische Chemie, Brüderstraße 34, 04103, Leipzig, Germany

For all author emails, please log on.

BMC Biotechnology 2012, 12:56  doi:10.1186/1472-6750-12-56

Published: 23 August 2012

Abstract

Background

Covalent linkage of the ubiquitin-like protein ISG15 interferes with viral infection and USP18 is the major protease which specifically removes ISG15 from target proteins. Thus, boosting ISG15 modification by protease inhibition of USP18 might represent a new strategy to interfere with viral replication. However, so far no heterologous expression system was available to yield sufficient amounts of catalytically active protein for high-throughput based inhibitor screens.

Results

High-level heterologous expression of USP18 was achieved by applying a chaperone-based fusion system in E. coli. Pure protein was obtained in a single-step on IMAC via a His6-tag. The USP18 fusion protein exhibited enzymatic activity towards cell derived ISG15 conjugated substrates and efficiently hydrolyzed ISG15-AMC. Specificity towards ISG15 was shown by covalent adduct formation with ISG15 vinyl sulfone but not with ubiquitin vinyl sulfone.

Conclusion

The results presented here show that a chaperone fusion system can provide high yields of proteins that are difficult to express. The USP18 protein obtained here is suited to setup high-throughput small molecule inhibitor screens and forms the basis for detailed biochemical and structural characterization.